Hudson Bay Capital Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.98M | Sell |
965,000
-280,900
| -23% | -$868K | 0.01% | 486 |
|
|
2025
Q1 | $4.35M | Buy |
1,245,900
+133,400
| +12% | +$466K | 0.01% | 377 |
|
|
2024
Q4 | $3.64M | Buy |
1,112,500
+82,500
| +8% | +$270K | 0.01% | 413 |
|
|
2024
Q3 | $3.97M | Sell |
1,030,000
-655,000
| -39% | -$2.52M | 0.02% | 336 |
|
|
2024
Q2 | $5.21M | Sell |
1,685,000
-1,835,382
| -52% | -$5.67M | 0.02% | 291 |
|
|
2024
Q1 | $9.08M | Sell |
3,520,382
-619,522
| -15% | -$1.6M | 0.05% | 148 |
|
|
2023
Q4 | $10.3M | Sell |
4,139,904
-10,000
| -0.2% | -$25K | 0.07% | 147 |
|
|
2023
Q3 | $8.42M | Buy |
4,149,904
+1,302,978
| +46% | +$2.65M | 0.07% | 160 |
|
|
2023
Q2 | $6.55M | Buy |
2,846,926
+110,500
| +4% | +$254K | 0.05% | 217 |
|
|
2023
Q1 | $8.29M | Sell |
2,736,426
-2,114,990
| -44% | -$6.41M | 0.07% | 169 |
|
|
2022
Q4 | $11.3M | Sell |
4,851,416
-110,479
| -2% | -$257K | 0.12% | 133 |
|
|
2022
Q3 | $9.48M | Buy |
4,961,895
+293,668
| +6% | +$561K | 0.08% | 172 |
|
|
2022
Q2 | $12.7M | Buy |
4,668,227
+184,900
| +4% | +$501K | 0.1% | 113 |
|
|
2022
Q1 | $13.4M | Buy |
4,483,327
+2,677,627
| +148% | +$7.98M | 0.18% | 82 |
|
|
2021
Q4 | $7.02M | Buy |
1,805,700
+5,700
| +0.3% | +$22.2K | 0.07% | 218 |
|
|
2021
Q3 | $7.72M | Hold |
1,800,000
| – | – | 0.1% | 191 |
|
|
2021
Q2 | $5.45M | Buy |
1,800,000
+400,000
| +29% | +$1.21M | 0.07% | 299 |
|
|
2021
Q1 | $4.66M | Buy |
1,400,000
+675,000
| +93% | +$2.25M | 0.06% | 318 |
|
|
2020
Q4 | $2.57M | Buy |
725,000
+15,000
| +2% | +$53.3K | 0.03% | 329 |
|
|
2020
Q3 | $2.22M | Sell |
710,000
-265,000
| -27% | -$829K | 0.03% | 328 |
|
|
2020
Q2 | $1.77M | Buy |
975,000
+175,000
| +22% | +$318K | 0.03% | 318 |
|
|
2020
Q1 | $808K | Sell |
800,000
-50,000
| -6% | -$50.5K | 0.02% | 337 |
|
|
2019
Q4 | $2.36M | Sell |
850,000
-45,000
| -5% | -$125K | 0.05% | 244 |
|
|
2019
Q3 | $1.37M | Buy |
895,000
+10,000
| +1% | +$15.3K | 0.04% | 272 |
|
|
2019
Q2 | $1.84M | Buy |
885,000
+235,000
| +36% | +$489K | 0.04% | 255 |
|
|
2019
Q1 | $2.33M | Hold |
650,000
| – | – | 0.03% | 256 |
|
|
2018
Q4 | $2.49M | Buy |
650,000
+500,000
| +333% | +$1.92M | 0.03% | 247 |
|
|
2018
Q3 | $1.42M | Sell |
150,000
-35,000
| -19% | -$331K | 0.02% | 326 |
|
|
2018
Q2 | $1.35M | Sell |
185,000
-175,000
| -49% | -$1.28M | 0.02% | 332 |
|
|
2018
Q1 | $1.8M | Sell |
360,000
-40,000
| -10% | -$200K | 0.04% | 261 |
|
|
2017
Q4 | $2.02M | Buy |
400,000
+282,000
| +239% | +$1.42M | 0.04% | 220 |
|
|
2017
Q3 | $732K | Sell |
118,000
-177,000
| -60% | -$1.1M | 0.02% | 249 |
|
|
2017
Q2 | $1.06M | Buy |
295,000
+37,012
| +14% | +$133K | 0.02% | 251 |
|
|
2017
Q1 | $838K | Buy |
+257,988
| New | +$838K | 0.01% | 306 |
|